These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24349396)

  • 1. A low serum bicarbonate concentration as a risk factor for mortality in peritoneal dialysis patients.
    Chang TI; Oh HJ; Kang EW; Yoo TH; Shin SK; Kang SW; Choi KH; Han DS; Han SH
    PLoS One; 2013; 8(12):e82912. PubMed ID: 24349396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low Serum Bicarbonate Predicts Residual Renal Function Loss in Peritoneal Dialysis Patients.
    Chang TI; Kang EW; Kim HW; Ryu GW; Park CH; Park JT; Yoo TH; Shin SK; Kang SW; Choi KH; Han DS; Han SH
    Medicine (Baltimore); 2015 Aug; 94(31):e1276. PubMed ID: 26252296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction of metabolic acidosis and its effect on albumin in chronic hemodialysis patients.
    Brady JP; Hasbargen JA
    Am J Kidney Dis; 1998 Jan; 31(1):35-40. PubMed ID: 9428449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of predialysis serum bicarbonate levels with risk of mortality and hospitalization in the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Bommer J; Locatelli F; Satayathum S; Keen ML; Goodkin DA; Saito A; Akiba T; Port FK; Young EW
    Am J Kidney Dis; 2004 Oct; 44(4):661-71. PubMed ID: 15384017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Serum Bicarbonate Levels on Muscle Mass and Kidney Function in Pre-Dialysis Chronic Kidney Disease Patients.
    Kittiskulnam P; Srijaruneruang S; Chulakadabba A; Thokanit NS; Praditpornsilpa K; Tungsanga K; Eiam-Ong S
    Am J Nephrol; 2020; 51(1):24-34. PubMed ID: 31752000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study.
    Dobre M; Yang W; Chen J; Drawz P; Hamm LL; Horwitz E; Hostetter T; Jaar B; Lora CM; Nessel L; Ojo A; Scialla J; Steigerwalt S; Teal V; Wolf M; Rahman M;
    Am J Kidney Dis; 2013 Oct; 62(4):670-8. PubMed ID: 23489677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic acidosis in peritoneal dialysis patients: the role of residual renal function.
    Tian XK; Shan YS; Zhe XW; Cheng LT; Wang T
    Blood Purif; 2005; 23(6):459-65. PubMed ID: 16244471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyponatremia as a predictor of mortality in peritoneal dialysis patients.
    Chang TI; Kim YL; Kim H; Ryu GW; Kang EW; Park JT; Yoo TH; Shin SK; Kang SW; Choi KH; Han DS; Han SH
    PLoS One; 2014; 9(10):e111373. PubMed ID: 25354265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dialysis modality and correction of uremic metabolic acidosis: relationship with all-cause and cause-specific mortality.
    Vashistha T; Kalantar-Zadeh K; Molnar MZ; Torlén K; Mehrotra R
    Clin J Am Soc Nephrol; 2013 Feb; 8(2):254-64. PubMed ID: 23184567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic acidosis is associated with increased risk of adverse kidney outcomes and mortality in patients with non-dialysis dependent chronic kidney disease: an observational cohort study.
    Tangri N; Reaven NL; Funk SE; Ferguson TW; Collister D; Mathur V
    BMC Nephrol; 2021 May; 22(1):185. PubMed ID: 34011303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between residual renal function, inflammation and patient survival in new peritoneal dialysis patients.
    Chung SH; Heimbürger O; Stenvinkel P; Qureshi AR; Lindholm B
    Nephrol Dial Transplant; 2003 Mar; 18(3):590-7. PubMed ID: 12584284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease.
    Eustace JA; Astor B; Muntner PM; Ikizler TA; Coresh J
    Kidney Int; 2004 Mar; 65(3):1031-40. PubMed ID: 14871424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction of metabolic acidosis on serum albumin and protein catabolism in hemodialysis patients.
    Movilli E; Viola BF; Camerini C; Mazzola G; Cancarini GC
    J Ren Nutr; 2009 Mar; 19(2):172-7. PubMed ID: 19218045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial).
    Schutte E; Lambers Heerspink HJ; Lutgers HL; Bakker SJ; Vart P; Wolffenbuttel BH; Umanath K; Lewis JB; de Zeeuw D; Gansevoort RT
    Am J Kidney Dis; 2015 Sep; 66(3):450-8. PubMed ID: 25987260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal and cross-sectional effects of C-reactive protein, equilibrated normalized protein catabolic rate, and serum bicarbonate on creatinine and albumin levels in dialysis patients.
    Kaysen GA; Greene T; Daugirdas JT; Kimmel PL; Schulman GW; Toto RD; Levin NW; Yan G;
    Am J Kidney Dis; 2003 Dec; 42(6):1200-11. PubMed ID: 14655192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients.
    Wang AY; Wang M; Woo J; Lam CW; Lui SF; Li PK; Sanderson JE
    J Am Soc Nephrol; 2004 Aug; 15(8):2186-94. PubMed ID: 15284304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term clinical experience with pure bicarbonate peritoneal dialysis solutions.
    Montenegro J; Saracho RM; Martínez IM; Muñoz RI; Ocharan JJ; Valladares E
    Perit Dial Int; 2006; 26(1):89-94. PubMed ID: 16538881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acid-base profile and predictors of metabolic acidosis in patients undergoing peritoneal dialysis with lactate- and bicarbonate-buffered peritoneal dialysis solutions.
    Fourtounas C; Savidaki E; Roumelioti M; Dousdampanis P; Hardalias A; Kalliakmani P; Papachristou E; Drakopoulos A; Goumenos DS; Vlachojannis JG
    Adv Perit Dial; 2006; 22():187-91. PubMed ID: 16983967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of peritoneal transport rate and dialysis adequacy with inflammation in peritoneal dialysis patients.
    Fein PA; Fazil I; Rafiq MA; Schloth T; Matza B; Chattopadhyay J; Avram MM
    Adv Perit Dial; 2006; 22():2-6. PubMed ID: 16983929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Fast Decline of Residual Renal Function in the First Year is a Predictor for Early Withdrawal from Peritoneal Dialysis in Non-Diabetic Patients.
    Wang J; Xie X; Yan X; Yang X; Zhang X; Chen J; Han F
    Kidney Blood Press Res; 2019; 44(1):12-21. PubMed ID: 30808853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.